2019 Annual Meeting Education Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Patents, Royalties, Travel, Stock and Other Expert Name Employment Leadership Honoraria Consulting or Advisory Role Speakers' Bureau Research Funding Other Intellectual Accommodations, Other Ownership Interests Testimony Property Expenses Monica M. Abbvie (Inst), Agenus (Inst), Astellas Bertagnolli Pharma (Inst), AstraZeneca (Inst), Baxalta (Inst), Bayer Health (Inst), Breast Cancer Research Foundation (Inst), Bristol- Myers Squibb (Inst), Celgene (Inst), Complion (Inst), Eisai (Inst), Exelixis (Inst), Genentech (Inst), GHI Pharma (Inst), Gilead Sciences (Inst), GlaxoSmithKline (Inst), Incyte (Inst), Janssen (Inst), Jazz Pharmaceuticals (Inst), Leidos (Inst), Lexicon (Inst), Lilly (Inst), Matrex (Inst), Mayo Clinic (Inst), Merck (Inst), MGH (Inst), Millenium Pharamceuticals (Inst), Novartis (Inst), PCORI (Inst), Pfizer (Inst), Pharmacyclics (Inst), Robert Wood Johnson Foundation (Inst), Sagerock Advisors (Inst), Sanofi (Inst), Taiho Oncology (Inst), Takeda (Inst), Tesaro (Inst), Teva (Inst) Tatiana M. Prowell David R. Spigel AstraZeneca (Inst), Boehringer AstraZeneca (Inst), Boehringer Ingelheim (Inst), Bristol-Myers Ingelheim (Inst), Bristol-Myers Squibb Squibb (Inst), Celgene (Inst), (Inst), Celgene (Inst), Genentech/Roche Genentech/Roche (Inst), (Inst), Lilly (Inst), Merck (Inst), Novartis Novartis (Inst), Pfizer (Inst) (Inst), Pfizer (Inst), University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst) Colin D. Weekes Celgene, Lilly, Merrimack Celgene, Merrimack Abbvie, Bayer, Celgene, Genentech/Roche, Lilly, Millennium Breast Cancer Neelima Denduluri Amgen (Inst), Genentech (Inst), Novartis (Inst) Rebecca A. Dent AstraZeneca, Lilly, Pfizer, AstraZeneca, Eisai, Merck, Amgen, Pfizer, Roche Roche/ Pfizer, Roche Genentech Kelly Hunt Armada Health Care Endomagnetics (Inst) Sara A. Hurvitz Ambryx (Inst), Amgen (Inst), Bayer (Inst), Lilly, Novartis, OBI Biomarin (Inst), Boehringer Ingelheim Pharma (Inst), Cascadian Therapeutics (Inst), Daiichi Sankyo (Inst), Dignitana (Inst), Genentech/Roche (Inst), GlaxoSmithKline (Inst), Lilly (Inst), Macrogenics (Inst), Medivation (Inst), Merrimack (Inst), Novartis (Inst), OBI Pharma (Inst), Pfizer (Inst), Puma Biotechnology (Inst), Sanofi (Inst), Seattle Genetics (Inst) Alberto J. Montero Johnson & Johnson Celgene New Century Health Stacy L. Moulder Novartis Bayer (Inst), Genentech (Inst), Novartis Novartis (Inst), Oncothyreon (Inst), Pfizer (Inst), Takeda (Inst) Erica M. Stringer- Breast Cancer Index, Lilly Immunomedics Susan G. Komen for the Cure Cascadian Reasor Therapeutics Alexandra Thomas Gilead Sciences, BeyondSpring Pharmaceuticals Syndax (Inst) Up-to-Date Royalties (I) Johnson & Johnson (I) Cancer Prevention, Hereditary Genetics, and Epidemiology Banu Arun Abbvie, PharmaMar Jeff Boyd Joanne M. Jeter Pfizer Bristol-Myers Squibb, Merck Pfizer Sailaja Kamaraju Prudence B. Lam Myriad Genetics Myriad Genetics Howard L. McLeod Cancer Genetics, Genentech/Roche Cancer Genetics, Gentris, Interpares Biomedicine NIH/NCI, Saladax Biomedical Michael P. Mullane Victoria L. Seewaldt Gina M. Villani Anthony Alberg (Liaison) Care Delivery and Practice Management Edward Arrowsmith Tennessee Flatiron Health Flatiron Health Sarah Oncology Cannon Research Suzanne Cole Research to Practice Robert M. Daly Quadrant CVS Health, Johnson & Holdings Johnson, Lilly (I), McKesson, Quadrant Holdings (I), Walgreens Boots Alliance (I), Walgreens Boots Alliance Kurt C. Demel Gilead Sciences, Pfizer Sue Sun Yom BioMimetix Bristol-Myers Squibb (Inst), Genentech UpToDate, Springer (Inst), Merck (Inst) Paul Celano (Liaison) Leonard Saltz McNeil PPC (I) Taiho Pharmaceutical (Liaison) Central Nervous System Tumors Tracy Batchelor Champions, Amgen, GenomiCare, Merck, Genomicare, Merck, Biotechnology, NXDC Roche/Genentech Genomicare, Imedex, Merck, NXDC, UpToDate Priscilla K. Angiochem, Genentech, Angiochem, Genentech/ Merck, Pfizer Brastianos Merck Roche, Lilly Simon S. Lo Ingo K. Mellinghoff Developmental Immunotherapy and Tumor Immunobiology Todd M. Bauer Sarah Cannon Guardant Health, Ignyta (Inst), Abbvie (Inst), Aileron Therapeutics (Inst), Research Loxo, Amgen (Inst), Astellas Pharma (Inst), Institute, Moderna Therapeutics (Inst), AstraZeneca (Inst), Boehringer Tennessee Pfizer Ingelheim (Inst), Bristol-Myers Squibb Oncology (Inst), Calithera Biosciences (Inst), Clovis Oncology (Inst), Daiichi Sankyo (Inst), Deciphera (Inst), Five Prime Therapeutics (Inst), Foundation Medicine (Inst), Genentech/Roche (Inst), GlaxoSmithKline (Inst), Ignyta (Inst), Immunocore (Inst), Immunogen (Inst), Incyte (Inst), Jacobio (Inst), Janssen (Inst), Karyopharm Therapeutics (Inst), Kolltan Pharmaceuticals (Inst), Leap Therapeutics (Inst), Lilly (Inst), Loxo (Inst), MabVax (Inst), MedImmune (Inst), Medpacto (Inst), Merck (Inst), Merrimack (Inst), Millennium (Inst), Mirati Therapeutics (Inst), Moderna Therapeutics (Inst), Novartis (Inst), Onyx (Inst), Peleton (Inst), Pfizer (Inst), Phosplatin Therapeutics (Inst), Principa Biopharma (Inst), Roche (Inst), Sanofi (Inst), Stemline Therapeutics (Inst), Takeda (Inst), Top Alliance BioScience (Inst) Benjamin Besse AstraZeneca (Inst), Boehringer Bristol-Myers Ingelheim (Inst), Bristol-Myers Squibb Squibb/Medarex, (Inst), Inivata (Inst), Lilly (Inst), Loxo Novartis, Pfizer, Pierre (Inst), Novartis (Inst), OncoMed (Inst), Fabre, Roche Onxeo (Inst), Ose Pharma (Inst), Pfizer (Inst), Roche/Genentech (Inst), SERVIER (Inst) Scott N. Gettinger Alexion Pharmaceuticals, ARIAD (Inst), Bristol-Myers Squibb (Inst), Merck Bristol-Myers Squibb, Genentech (Inst), Incyte (Inst), Pfizer Pfizer (Inst) Naoko Takebe Lei Zheng Z and L International AstraZeneca, Biosynergies, Amgen,Bristol-Myers Squibb, Gradalis, GVAX, licensed to Medical Merck, Merrimack, Novarock Halozyme, ITeos Therapeutics, Merck Aduro Biotech Lajos Pusztai Merck, AstraZeneca/ H3 Biomedicine, Merck, Merck, Genentech, Seattle Genetics, (Liaison) MedImmune, Pfizer, Novartis, PierianDx, Seattle AstraZeneca Syndax, Almac Genetics, Syndax Diagnostics, Pieris Pharmaceuticals, Genentech, Immunomedics, Eisai, Seattle Genetics/Astellas Developmental Therapeutics and Tumor Biology and (Nonimmuno) Ryan B. Corcoran Amgen, Astex Pharmaceuticals, AstraZeneca, Sanofi Avidity Nanomedicines, Bristol- Myers Squibb, FOG Pharma, Genentech, Loxo, Merrimack, N- of-One, Roche, Roivant, Shire, Spectrum Pharmaceuticals, Symphogen, Taiho Pharmaceutical, Warp Drive Bio David S. Hong MolecularMatch, Adaptimmune, Baxter, Bayer, Eisai, Abbvie, Adaptimmune, Amgen, Loxo, miRNA Oncorena Baxter, Bayer, Merrimack Genentech, GLG, Guidepoint AstraZeneca, Bayer, Bristol-Myers Therapeutics Global, Janssen Squibb, Daichii Sankyo, Eisai, Genentech, Genmab, Ignyta, Infinity Pharmaceuticals, Kite Pharma, Kyowa Hakko Kirin, Lilly, Loxo, MedImmune, Merck, Mirati Therapeutics, miRNA Therapeutics, Molecular Templates, Novartis, Pfizer, Seattle Genetics, Takeda Victoria M. Villaflor ARIAD/Takeda, AstraZeneca, ARIAD/Takeda, Genentech/Roche AstraZeneca Kwok-Kin Wong G1 Therapeutics Array BioPharma, AstraZeneca, Gilead Sciences, AstraZeneca, Genocea GlaxoSmithKline, Janssen Oncology Biosciences, Janssen (Inst), Janssen Oncology, Lilly Oncology, Lilly, Novartis, Ono Pharmaceutical Gastrointestinal (Colorectal) Cancer Nilofer S. Azad AMAG Pharmaceuticals, AMAG Pharmaceuticals, Agios (Inst), Array BioPharma (Inst), Bayer/Onyx DAVA Oncology Astex Pharmaceuticals (Inst), Bristol- Myers Squibb (Inst), Celgene (Inst), Genentech (Inst), Intensity Therapeutics, Merck (Inst), Syndax (Inst) Sharlene Gill Amgen, Bristol-Myers Squibb, Taiho Pharmaceutical Celgene Celgene, Lilly, Shire, Taiho Pharmaceutical Arden M. Morris Michael J. Overman Bristol-Myers Squibb, Amgen, Bristol-Myers Squibb, Celgene, Merrimack, Roche/Genentech MedImmune, Merck, Roche Weijing Sun Genentech/Roche, Bayer Bayer, Merck (Inst) Taiho Pharmaceutical Gastrointestinal (Noncolorectal) Cancer Ian Chau Gilead Sciences, Lilly Bristol-Myers Squibb, Lilly, Janssen-Cilag (Inst), Lilly (Inst), Merck Bristol-Myers Squibb, Merck Serono, MSD Oncology Serono (Inst), Sanofi (Inst) Lilly, Merck Serono, MSD, Sanofi Ramon A. De Mello AstraZeneca, Novartis MSD Oncology, Pfizer AstraZeneca Amgen, AstraZeneca, Zodiac Merck, Pierre Fabre, Roche Peter C. Enzinger Astellas Pharma, Five Prime Therapeutics, Merck, Taiho Pharmaceutical Lipika Goyal Taiho Pharmaceutical Taiho Pharmaceutical James Posey Circulogene Lilly Theranostics Federico A. Sanchez Via Oncology Genitourinary (Nonprostate) Cancer Jeanny B. Aragon- Bristol-Myers Squibb Algeta/Bayer, AstraZeneca, Astellas Pharma, Bristol- Algeta/Bayer, Ching Dendreon, Janssen Biotech Myers Squibb, Janssen- Dendreon Ortho James Brugarolas Nektar Genentech/Roche Patent of HIF-2 Nektar biomarker (Inst) Primo Lara Pfizer Abbvie, AstraZeneca, Bayer, Aragon Pharmaceuticals (Inst), Bristol-Myers Squibb, CellMax Genentech (Inst), GlaxoSmithKline (Inst), Life, Exelixis, Foundation Heat Biologics (Inst), Incyte (Inst), Medicine, Genentech/Roche, Janssen Biotech (Inst), Merck (Inst), Janssen, Merck, Nektar, Pfizer, Millennium (Inst), Pharmacyclics (Inst), Turnstone Bio Polaris (Inst), TRACON Pharma (Inst) Bradley A. McGregor Astellas Pharma, AstraZeneca, Bayer, Exelixis, Genentech/Roche, Nextar, Seattle, Genetics/Astellas Evan Y. Yu Amgen, AstraZeneca, Bayer, Agensys (Inst), Astellas Pharma (Inst), Churchill, Pharmaceuticals,